Quick Answer
ONCOLYTICS BIOTECH INC reported Cash and Equivalents of $5.20 million for fiscal year 2025.
ONCOLYTICS BIOTECH INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $5.20M | -53.0% |
| 2024 | $11.08M | — |
- ONCOLYTICS BIOTECH INC showed a decrease of -53.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, ONCOLYTICS BIOTECH INC’s cash and equivalents has declined by 53.0% (from $11.08 million to $5.20 million).
- The most recent figure is from ONCOLYTICS BIOTECH INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: